首页> 外文期刊>The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics >When public health and genetic privacy collide: positive and normative theories explaining how ACA's expansion of corporate wellness programs conflicts with GINA's privacy rules.
【24h】

When public health and genetic privacy collide: positive and normative theories explaining how ACA's expansion of corporate wellness programs conflicts with GINA's privacy rules.

机译:当公共卫生与遗传隐私冲突时:积极和规范的理论解释了ACA公司健康计划的扩展如何与GINA的隐私规则相冲突。

获取原文
获取原文并翻译 | 示例
       

摘要

The Patient Protection and Affordable Care Act of 2010 (ACA) contains many provisions intended to increase access to and lower the cost of health care by adopting public health measures. One of these promotes the use of at-work wellness programs by both providing employers with grants to develop these programs and also increasing their ability to tie the price employees pay for health insurance for participating in these programs and meeting specific health goals. Yet despite ACA's specific alteration of three different statues which had in the past shielded employees from having to contribute to the cost of their health insurance based on their achieving employer-designated health markers, it chose to leave alone recently enacted rules implementing the Genetic Non-Discrimination Act (GINA), which prohibits employers from asking employees about their family health history in any context, including assessing their risk for setting wellness targets. This article reviews how both the changes made by ACA and the restrictions recently put place by GINA will affect the way employers are likely to structure Wellness Programs. It also considers how these changes reflect the competing social goals of both ACA, which seeks to expand access to the population by lowering costs, and GINA, which seeks to protect individuals from discrimination. It does so by analyzing both positive theories about how these new laws will function and normative theories explaining the likelihood of future friction between the interests of the population of the United States as a whole who are in need of increased and affordable access to health care, and of the individuals living in this country who risk discrimination, as science and medicine continue to make advances in linking genetic make-up to risk of future illness.
机译:《 2010年患者保护和负担得起的护理法案》(ACA)包含许多条款,旨在通过采取公共卫生措施来增加获得医疗服务的机会并降低医疗费用。其中之一通过向雇主提供补助金来开发这些计划,并提高他们对雇员为参加这些计划并满足特定健康目标而购买的健康保险所支付的价格进行定价的能力,来促进工作中健康计划的使用。然而,尽管ACA对三个不同的雕像进行了特定的改动,过去这些雕像使雇员不必根据其达到雇主指定的健康指标来负担其健康保险的费用,但它选择不采用最近颁布的实施《遗传非基因药》的规则。 《歧视法》(GINA)禁止雇主在任何情况下询问雇员其家庭健康史,包括评估设定健康目标的风险。本文回顾了ACA所做的更改以及GINA最近施加的限制将如何影响雇主构建健康计划的方式。它还考虑了这些变化如何反映了ACA和GINA的竞争性社会目标,ACA旨在通过降低成本来扩大与人口的接触,GINA旨在保护个人免受歧视。它通过分析有关这些新法律将如何运作的积极理论和解释将需要增加和负担得起的医疗保健机会的整个美国人口利益之间未来冲突可能性的规范理论来进行分析,随着科学和医学在将基因组成与将来患病风险联系起来方面继续取得进展,居住在这个国家的个人有遭受歧视的风险。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号